Key points are not available for this paper at this time.
The A/A genotype, which may represent a CYP1A2 high inducibility genotype, may either be a direct cause of increased CYP1A2 activity, or be genetically linked to polymorphisms conferring high inducibility. Further studies are needed to define the role of this polymorphism on the pharmacokinetics of drugs metabolised by CYP1A2 and in the activation of carcinogens.
Building similarity graph...
Analyzing shared references across papers
Loading...
Christoph Sachse
Jürgen Brockmöller
Steffen Bauer
British Journal of Clinical Pharmacology
Charité - Universitätsmedizin Berlin
Humboldt-Universität zu Berlin
Building similarity graph...
Analyzing shared references across papers
Loading...
Sachse et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d8e77a2c87b79b92d180f8 — DOI: https://doi.org/10.1046/j.1365-2125.1999.00898.x